Cours BioLargo, Inc. Other OTC
Actions
BLGO
US09065A1007
Produits chimiques de base
CA 2024 * | 19,05 M 17,25 M | CA 2025 * | 25,76 M 23,34 M | Capitalisation | 104 M 94,53 M |
---|---|---|---|---|---|
Résultat net 2024 * | -1 M -906 k | Résultat net 2025 * | - 0 | VE / CA 2024 * | 5,48 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 4,05 x |
PER 2024 * |
-35,3
x | PER 2025 * |
-
| Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 85,77% |
Dernier transcript sur BioLargo, Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 01/06/02 |
Director of Finance/CFO | 68 | 01/02/08 | |
Chief Operating Officer | 55 | 01/06/02 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 28/04/06 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 01/04/07 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 01/06/02 |
Varia. 1 janv. | Capi. | |
---|---|---|
+5,97% | 105 Md | |
-4,19% | 63,99 Md | |
+51,90% | 42,95 Md | |
+17,44% | 39,2 Md | |
+6,62% | 33,01 Md | |
+13,00% | 20,33 Md | |
+15,64% | 17,29 Md | |
+22,55% | 15,72 Md | |
+7,34% | 14,72 Md |